-
2024-514972-42-00
Thyroid eye disease 5 2025-02-25
-
2024-515702-63-00
Moderate-to-Severe Active Thyroid Eye Disease 5 2025-02-20
-
2024-513356-15-00
Acquired Blepharoptosis 5 2024-12-30
-
2023-505802-40-02
glaucoma 6 2024-10-09
-
2024-512268-77-00
Cataract 6 2024-10-02
-
2023-504751-28-00
Exudative age-related macular degeneration 5 2024-09-24
-
2024-510741-33-00
Macular degeneration 4 2024-06-27
-
2023-509469-19-00
Non-Infectious Uveitis affecting the posterior segment 11 2024-04-17
-
2024-517606-29-00
Central retinal artery occlusion 5 2020-10-30
-
2025-523367-38-00
Postoperative inflammation after cataract surgery 5 2026-05-11
-
2025-523937-25-00
Diabetic Macular Edema (DME) 5 2026-05-06
-
2025-523938-10-00
Diabetic Macular Edema (DME) 5 2026-05-05
-
2024-513174-22-00
Atrophic Age-related Macular Degeneration (AMD) 4 2026-04-14
-
2025-522231-34-00
Diabetic Macular Edema 5 2026-03-31
-
2024-518758-18-02
Diabetic retinopathy. 1 2026-03-03
-
2025-522701-38-00
SUBRETINAL HYPERREFLECTIVE MATERIAL 6 2026-02-26
-
2025-524527-46-00
Ocular inflammatory conditions 1 2026-02-16
-
2025-523339-20-00
Leber Hereditary Optic Neuropathy due to mutations in t 4 2026-01-20
-
2024-512298-28-00
Neovascular age-related macular degeneration 11 2025-12-18
-
2025-521349-25-00
Macular neovascularization secondary to age-related mac 5 2025-12-09
-
2025-522291-83-00
Atopic Keratoconjunctivitis 5 2025-11-27
-
2024-520384-14-00
Centre-involved diabetic macular edema 4 2025-11-20
-
2024-518969-98-00
Neurotrophic Keratopathy 5 2025-11-04
-
2024-514110-12-00
Thyroid Eye Disease 7 2025-10-22